joining everyone, you afternoon, thank earnings for and call. Good our
year difficult second half net of first decreased CVD. revenue a of the As loss as result XXXX was and of XXXX, XXXX we previously mentioned, order a And the a of in for quarter reported $X.X levels. million low
that XXXX, focus facility the million purchased its building the compared in with is flow house for to has as Company now in off and has however, Further, of on of receipt new the In of improvement Materials. first accelerated materials The CVD $X.X materials XXXX, remainder to the the during to $XX order started Company sight. million, orders of quarter we XXXX. anticipate opening the year the amounting the approximately business
as well invested in the expenses. first as building XXXX $X.X improvements $XXX,XXX other additional million the machinery quarter and XXXX, an of materials-related in Company During and
operations our at have new showcase operations facility to our materials marketing we coming XXXX the started materials investment and online CVD continued our the Materials, and during customers. of existing and the enhancing With in efforts to third quarter new are
underway MesoScribe California costs. the on new York to our complete with of are operations facility we to in The improvements and enhances from in to our materials MesoScribe execute to July into of consolidating move Additionally, ability our and integration operations the be completed reduce materials facility XXXX. expect operational New
research Air first received the innovation Force. During the from I business MesoScribe U.S. quarter, small awards two Phase
advanced The to is flux development first to related the hypersonic of award testing. system sensors temperature support and flight heat
technology need second the a base. our deposit our operations revenue award over for develop to grows further Direct during pharma, Materials diversifies masking materials offerings, ago expands materials two medical, strategy applications. other applications; CVD a eliminate materials, carbon for our subsidiary utilizing business provide, manufacturing substrate to aero metallic customer and medical MesoScribe's through Write for engine CVD's on turbine subsidiary embarked applications; abilities aerospace subsidiary for through aperture for years MesoScribe coatings, one, two, The for applications is materials oil port material, industrial The gas expansion of defense, through deposition. and our corrosion-resistant and proprietary CVD for capability electronic and and Tantaline product and development medical sensors coatings three, to system enhance coatings using equipment defense, composite our aerospace, and our system, ceramic printing coatings and The and our into
reduce risk the our and coatings markets results. to corrosion-resistant in uneven levels aerospace defense growth We are tapping into flatten of and high-margin medical,
over call CFO, I that, quarterly to QX to turn We would returning results by With the XXXX. Tom our committed like to McNeill. profitable are to